Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Kane Biotech Inc
V.KNE
Alternate Symbol(s):
KNBIF
Healthcare
Biotechnology
Kane Biotech Inc. is a Canada-based biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms. The Company has a portfolio of biotechnologies, intellectual property (66 patents and patents pending, trade secrets and trademarks) and products developed by its own biofilm research expertise and acquired...
from research institutions. DispersinB, coactiv+, coactiv+, DermaKB, DermaKB Biofilm, and revive are trademarks of the Company. Its patented coactiv+ technology is specifically formulated to destabilize biofilm and create an environment for fast wound healing. In Wound Care & Surgical applications, in addition to revyve Antimicrobial Wound Gel, it is developing follow-on products with three applications: coactiv+ Antimicrobial Surgical Hydrogel, coactiv+ Antimicrobial Wound Gel Spray, and coactiv+ Antimicrobial Wound Rinse. The Company's other biofilm disruption technology is DispersinB.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSXV:KNE)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
21
22
23
24
25
26
27
28
29
Next
(75)
•••
francoisl13
X
View Profile
View Bullboard History
Comment by
francoisl13
on Feb 06, 2023 12:21pm
RE:Promotion
I think that this article provides us with an answer regarding the coactiv+ 510K approval process; ''The review process is well underway, and approval is expected by the second
...more
(2174)
•••
lscfa
X
View Profile
View Bullboard History
Post by
lscfa
on Feb 06, 2023 9:52am
Promotion
https://www.thenewswire.com/press-releases/1BOxFG27E-kane-biotechs-coactiv-tm-technology-could-address-a-pricey-and-painful-problem-lack-of-healing-in-chronic-wounds-due-to-microbial-biofilm-formation
...more
(202)
•••
RoyMax123
X
View Profile
View Bullboard History
Comment by
RoyMax123
on Jan 27, 2023 1:04pm
RE:RE:RE:News Release: Further information…
BTW, He also posted that vids, listen at around 2Min https://www.paidpromotionalmessages.com/companies/news/1004091/kane-biotech-announces-distribution-agreement-for-coactiv-antimicrobial-hydrogel
...more
(202)
•••
RoyMax123
X
View Profile
View Bullboard History
Comment by
RoyMax123
on Jan 27, 2023 1:00pm
RE:RE:News Release: Further information…
someone posted this on CEO https://ceo.ca/kne?af99af499987 So I think we'll have to wait a bit more.
(75)
•••
francoisl13
X
View Profile
View Bullboard History
Post by
francoisl13
on Jan 27, 2023 11:46am
Animalcare plc - Plaqtiv+ comment in note to shareholders
It looks like the Plaqtiv+ line of products is performing well in Europe, this is an excerpt from the latest note to shareholder from Animalcare; ''Notably, Daxocox is now comfortably a top 10
...more
(75)
•••
francoisl13
X
View Profile
View Bullboard History
Comment by
francoisl13
on Jan 27, 2023 10:28am
RE:News Release: Further information…
The FDA site is updated every Monday (see lik below); CRDH 510k Approval database Based on KNE submitting their file in October and info provided by MirroWorldMan, I expect the coactiv+ approval to be
...more
(11)
•••
pibopibopibopib
X
View Profile
View Bullboard History
Post by
pibopibopibopib
on Jan 04, 2023 11:39pm
Finally
More question rest but we start.....
(72)
•••
MirrorWorldMan
X
View Profile
View Bullboard History
Post by
MirrorWorldMan
on Jan 04, 2023 10:28am
News our
Nice to see partnerships already signed in anticipation of approaching 510 k approval. Provides validation to medical need, providing a magnitude of dollar numbers is necessary to evaluate value
...more
(37)
•••
BryceCanada
X
View Profile
View Bullboard History
Post by
BryceCanada
on Dec 11, 2022 4:57pm
Nice biotech read!
https://biotechstockmarketnews.com/this-living-cure-targets-only-cancer-cells/?utm_source=mcnalliemoney&utm_medium=influencer&utm_campaign=albtz_us
(72)
•••
MirrorWorldMan
X
View Profile
View Bullboard History
Post by
MirrorWorldMan
on Nov 03, 2022 2:19pm
News Release: Further information…
"The FDA goal to make a MDUFA Decision for a 510(k) is 90 FDA Days. FDA Days are calculated as the number of calendar days between the date the 510(k) was received and the date of a MDUFA
...more
(72)
•••
MirrorWorldMan
X
View Profile
View Bullboard History
Comment by
MirrorWorldMan
on Oct 04, 2022 3:42pm
RE:Funding from US Dept of Defense
Markets are pessimistic, solid revenue, license sales or buyouts seem the only way to lift value these days
(2174)
•••
lscfa
X
View Profile
View Bullboard History
Post by
lscfa
on Oct 04, 2022 10:02am
Funding from US Dept of Defense
https://www.globenewswire.com/news-release/2022/10/04/2527713/0/en/Kane-Biotech-Receives-an-Additional-425K-USD-of-Funding-for-its-DispersinB-Hydrogel-from-the-United-States-Department-of-Defense.html
(28)
•••
ARIMA11
X
View Profile
View Bullboard History
Post by
ARIMA11
on Aug 04, 2022 9:12pm
Summary
https://www.rally-co.ca/post/kne-v-complexity
(72)
•••
MirrorWorldMan
X
View Profile
View Bullboard History
Post by
MirrorWorldMan
on May 26, 2022 4:31pm
Important Quote
" Kane is collaborating with the FDA on our coactiv+™ 510(k) application for which a positive pre-submission meeting was recently held and a clear path forward was established" This
...more
Prev
...
21
22
23
24
25
26
27
28
29
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
One Property, One Focus on Advancing this Gold Project in Ontario
Options Trading for Retiring: Key Strategies in Balancing Retirement Income